![]() |
|
|
Vol. 296, Issue 3, 1006-1012, March 2001
Laboratory for Cancer Medicine, Western Australian Institute for
Medical Research, Royal Perth Hospital and Department of Pharmacology,
University of Western Australia, Perth, Western Australia
DNA that enters the circulation is rapidly cleared both by tissue
uptake and by DNase-mediated degradation. In this study, we have
examined the uptake of linear plasmid DNA in an isolated perfused liver
model and following intra-arterial administration to rats. We found
that the DNA was rapidly taken up by the isolated perfused liver
without degradation. The single-pass extraction ratio was 0.76 ± 0.05, the mean transit time was 15.3 ± 3.6 s, and the
volume of distribution was 0.29 ± 0.07 ml/g. Hepatic uptake was
saturable and was inhibited by polyinosinic acid or polycationic liposomes but not by condensation of the DNA with polylysine. When the
linear plasmid DNA was administered in vivo, plasma half-life was
3.1 ± 0.2 min, volume of distribution was 670 ± 85 ml/kg, and clearance was 32 ± 4 ml/min. Coadministration of cationic liposomes decreased the volume of distribution to 180 ± 28 ml/kg as well as the half-life (2.6 ± 0.2 min). By contrast,
polyinosinic acid significantly increased the circulating half-life
(7.7 ± 0.5 min), decreased the volume of distribution (95 ± 17 ml/kg), and partially inhibited DNA degradation. When administered
along with the liposomes and the polyinosinic acid, the distribution of
plasmid-derived radioactivity decreased in the liver and increased in
most other peripheral tissues. This study shows that pharmacological manipulation of the uptake and degradation of DNA can alter its distribution and clearance in vivo. These results may be useful in
optimizing gene delivery procedures for in vivo gene therapy.
This article has been cited by other articles:
![]() |
P. J. Bastian, G. S. Palapattu, S. Yegnasubramanian, X. Lin, C. G. Rogers, L. A. Mangold, B. Trock, M. Eisenberger, A. W. Partin, and W. G. Nelson Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy Clin. Cancer Res., September 15, 2007; 13(18): 5361 - 5367. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bastian, G. S. Palapattu, X. Lin, S. Yegnasubramanian, L. A. Mangold, B. Trock, M. A. Eisenberger, A. W. Partin, and W. G. Nelson Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy Clin. Cancer Res., June 1, 2005; 11(11): 4037 - 4043. [Abstract] [Full Text] [PDF] |
||||